Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Magnesium Sulfate for VATS Lung Resection Analgesia
2023-509503-33-00Phase 4Authorised
- Sponsor
- Clínica Universidad de Navarra
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and magnesium sulfate in postoperative pain (4 arms), sponsored by Clínica Universidad de Navarra. Primary endpoint: Morphine consumption in the first 24 postoperative hours. Planned start May 2024; status: authorised.
02
Drugs
lidocainemagnesium sulfate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2023-509503-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509503-33-00.